keyword
https://read.qxmd.com/read/38645412/link-a-unveiling-its-functional-role-and-clinical-significance-in-human-tumors
#21
REVIEW
Bing Liao, Jialing Wang, Yilin Xie, Hongliang Luo, Jun Min
LINK-A, also recognized as LINC01139, has emerged as a key oncological lncRNA in cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer, ovarian cancer, glioma, non-small-cell lung cancer, and mantle cell lymphoma. Notably, LINK-A is involved in regulating critical cancer-related pathways, such as AKT and HIF1α signaling, and is implicated in a range of oncogenic activities, including cell proliferation, apoptosis, epithelial-mesenchymal transition (EMT), cell invasion and migration, and glycolysis reprogramming...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38645331/new-salicylanilide-derivatives-and-their-peptide-conjugates-as-anticancer-compounds-synthesis-characterization-and-in-vitro-effect-on-glioblastoma
#22
JOURNAL ARTICLE
Lilla Horváth, Beáta Biri-Kovács, Zsuzsa Baranyai, Bence Stipsicz, Előd Méhes, Bálint Jezsó, Martin Krátký, Jarmila Vinšová, Szilvia Bősze
Pharmacologically active salicylanilides (2-hydroxy- N -phenylbenzamides) have been a promising area of interest in medicinal chemistry-related research for quite some time. This group of compounds has shown a wide spectrum of biological activities, including but not limited to anticancer effects. In this study, substituted salicylanilides were chosen to evaluate the in vitro activity on U87 human glioblastoma (GBM) cells. The parent salicylanilide, salicylanilide 5-chloropyrazinoates, a 4-aminosalicylic acid derivative, and the new salicylanilide 4-formylbenzoates were chemically and in vitro characterized...
April 16, 2024: ACS Omega
https://read.qxmd.com/read/38645202/multi-pronged-analysis-of-pediatric-low-grade-glioma-reveals-a-unique-tumor-microenvironment-associated-with-braf-alterations
#23
Shadi Zahedi, Kent Riemondy, Andrea M Griesinger, Andrew M Donson, Rui Fu, Michele Crespo, John DeSisto, Madeline M Groat, Emil Bratbak, Adam Green, Todd C Hankinson, Michael Handler, Rajeev Vibhakar, Nicholas Willard, Nicholas K Foreman, Jean Mulcahy Levy
UNLABELLED: Pediatric low-grade gliomas (pLGG) comprise 35% of all brain tumors. Despite favorable survival, patients experience significant morbidity from disease and treatments. A deeper understanding of pLGG biology is essential to identify novel, more effective, and less toxic therapies. We utilized single cell RNA sequencing (scRNA-seq), spatial transcriptomics, and cytokine analyses to characterize and understand tumor and immune cell heterogeneity across pLGG. scRNA-seq revealed tumor and immune cells within the tumor microenvironment (TME)...
April 10, 2024: bioRxiv
https://read.qxmd.com/read/38645178/all-trans-retinoic-acid-induces-durable-tumor-immunity-in-idh-mutant-gliomas-by-rescuing-transcriptional-repression-of-the-crbp1-retinoic-acid-axis
#24
Aparna Rao, Xiaoran Zhang, Anthony R Cillo, Jonathan H Sussman, Poorva Sandlesh, Antonio Corral Tarbay, Arka N Mallela, Carly Cardello, Katharine Krueger, Jessica Xu, Alex Li, Jason Xu, Jonathan Patterson, Ebrar Akca, Angelo Angione, Emade Jaman, Wi Jin Kim, Jordan Allen, Abhishek Venketeswaran, Pascal O Zinn, Robert Parise, Jan Beumer, Anette Duensing, Eric C Holland, Robert Ferris, Stephen J Bagley, Tullia C Bruno, Dario A A Vignali, Sameer Agnihotri, Nduka M Amankulor
Diffuse gliomas are epigenetically dysregulated, immunologically cold, and fatal tumors characterized by mutations in isocitrate dehydrogenase (IDH). Although IDH mutations yield a uniquely immunosuppressive tumor microenvironment, the regulatory mechanisms that drive the immune landscape of IDH mutant (IDHm) gliomas remain unknown. Here, we reveal that transcriptional repression of retinoic acid (RA) pathway signaling impairs both innate and adaptive immune surveillance in IDHm glioma through epigenetic silencing of retinol binding protein 1 (RBP1) and induces a profound anti-inflammatory landscape marked by loss of inflammatory cell states and infiltration of suppressive myeloid phenotypes...
April 13, 2024: bioRxiv
https://read.qxmd.com/read/38645012/transcriptomic-and-proteomic-spatial-profiling-of-pediatric-and-adult-diffuse-midline-glioma-h3-k27-altered-reveals-region-specific-differences-and-limited-overlap-between-mrna-and-protein
#25
Sudarshawn Damodharan, Jack M Shireman, Elliot Xie, Emily Distler, Christina Kendziorski, Mahua Dey
Diffuse midline glioma, H3 K27 -altered (DMG-Alt) are highly aggressive malignancies of the central nervous system (CNS) that primarily affect the pediatric population. Large scale spatial transcriptomic studies have implicated that tumor microenvironmental landscape plays an important role in determining the phenotypic differences in tumor presentation and clinical course, however, data connecting overall transcriptomic changes to the protein level is lacking. The NanoString GeoMx™ Digital Spatial Profiler platform was used to determine the spatial transcriptomic and proteomic landscape in a cohort of both pediatric and adult H3 K27 -altered DMG biopsy samples...
April 5, 2024: Research Square
https://read.qxmd.com/read/38645003/pilot-trial-of-perampanel-on-peritumoral-hyperexcitability-and-clinical-outcomes-in-newly-diagnosed-high-grade-glioma
#26
Steven Tobochnik, Michael S Regan, Maria K C Dorotan, Dustine Reich, Emily Lapinskas, Md Amin Hossain, Sylwia A Stopka, Sandro Santagata, Melissa M Murphy, Omar Arnaout, Wenya L Bi, E Antonio Chiocca, Alexandra J Golby, Michael A Mooney, Timothy R Smith, Keith L Ligon, Patrick Y Wen, Nathalie Y R Agar, Jong Woo Lee
Background Glutamatergic neuron-glioma synaptogenesis and peritumoral hyperexcitability promote glioma growth in a positive feedback loop. The objective of this study was to evaluate the feasibility and estimated effect sizes of the AMPA-R antagonist, perampanel, on intraoperative electrophysiologic hyperexcitability and clinical outcomes. Methods An open-label trial was performed comparing perampanel to standard of care (SOC) in patients undergoing resection of newly-diagnosed radiologic high-grade glioma...
April 18, 2024: medRxiv
https://read.qxmd.com/read/38644819/dri-triton-ss-oct-applied-to-detect-choroidal-nodules-in-paediatric-patients-affected-by-nf1
#27
JOURNAL ARTICLE
Carlos Fresno Cañada, Joan Gispets Parcerisas, Cristina Del Prado Sánchez, Enric Puigventós Rosanas, Sara Perez-Jaume, Héctor Salvador, Ana Llorca Cardeñosa, Joan Prat Bartomeu
PURPOSE: To examine whether image processing of non-mydriatic DRI Triton SS-OCT (Topcon Corporation, Tokyo, Japan) using the red free filter could assess the presence of choroidal nodules and thus include their detection as a diagnostic criterion in neurofibromatosis type 1 (NF1). MATERIAL AND METHODS: We included 417 eyes from 210 patients, 377 - from 190 patients diagnosed with NF1 according to the criteria established by the National Institutes of Health Consensus Development Conference (NIH) and 40 from 20 healthy patients as a control group...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38644608/critical-roles-of-long-noncoding-rna-h19-in-cancer
#28
REVIEW
Darmadi Darmadi, Uliana Y Chugaeva, Raed Obaid Saleh, Ahmed Hjazi, Hiba Muwafaq Saleem, Pallavi Ghildiyal, Enas R Alwaily, Ahmed Alawadi, Mohammed Jawad Alnajar, Ali Ihsan
Long noncoding RNAs (lncRNAs) are a category of noncoding RNAs characterized by their length, often exceeding 200 nucleotides. There is a growing body of data that indicate the significant involvement of lncRNAs in a wide range of disorders, including cancer. lncRNA H19 was among the initial lncRNAs to be identified and is transcribed from the H19 gene. The H19 lncRNA exhibits significant upregulation in a diverse range of human malignancies, such as breast, colorectal, pancreatic, glioma, and gastric cancer...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38644565/radiotherapy-plus-temozolomide-with-or-without-anlotinib-in-h3k27m-mutant-diffuse-midline-glioma-a-retrospective-cohort-study
#29
JOURNAL ARTICLE
Chao Liu, Shuwen Kuang, Tianxiang Huang, Jun Wu, Longbo Zhang, Xuan Gong
BACKGROUND: Besides the hallmark of H3K27M mutation, aberrant amplifications of receptor tyrosine kinases (RTKs) are commonly observed in diffuse midline glioma (DMG), a highly malignant brain tumor with dismal prognosis. Here, we intended to evaluate the efficacy and safety of a multitarget RTK inhibitor anlotinib in patients with H3K27M-DMG. METHODS: A total of 40 newly diagnosed H3K27M-DMG patients including 15 with anlotinib and 25 without anlotinib treatment were retrospectively enrolled in this cohort...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38644422/efficacy-of-interstitial-photodynamic-therapy-using-talaporfin-sodium-and-a-semiconductor-laser-for-a-mouse-allograft-glioma-model
#30
JOURNAL ARTICLE
Kenta Nagai, Jiro Akimoto, Shinjiro Fukami, Yuki Saito, Emiyu Ogawa, Masakatsu Takanashi, Masahiko Kuroda, Michihiro Kohno
To investigate the therapeutic potential of photodynamic therapy (PDT) for malignant gliomas arising in unresectable sites, we investigated the effect of tumor tissue damage by interstitial PDT (i-PDT) using talaporfin sodium (TPS) in a mouse glioma model in which C6 glioma cells were implanted subcutaneously. A kinetic study of TPS demonstrated that a dose of 10 mg/kg and 90 min after administration was appropriate dose and timing for i-PDT. Performing i-PDT using a small-diameter plastic optical fiber demonstrated that an irradiation energy density of 100 J/cm2 or higher was required to achieve therapeutic effects over the entire tumor tissue...
April 21, 2024: Scientific Reports
https://read.qxmd.com/read/38644385/cylinder-tumor-surgery-in-pediatric-low-grade-gliomas
#31
REVIEW
Sebastian Gaston Jaimovich, Kazuhito Takeuchi, Victoria Tcherbbis Testa, Eriko Okumura, Roberto Jaimovich, Giuseppe Cinalli
BACKGROUND: Periventricular pediatric low-grade gliomas (pLGG) present a surgical challenge due to their deep-seated location, accessibility, and relationship with the subcortical network connections. Minimally invasive parafascicular approaches with tubular brain retractors (port brain surgery) have emerged, in recent years, as an alternative to conventional microsurgical and endoscopic approaches for removal of periventricular tumors. OBJECTIVES: To describe the minimally invasive approach with tubular brain retractors for periventricular pLGG, its technique, applications, safety, and efficacy...
April 22, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38644291/-analysis-of-the-safety-accuracy-and-factors-influencing-bleeding-complications-in-ct-guided-puncture-biopsy-of-brain-occupying-lesions
#32
JOURNAL ARTICLE
Y D Li, M Y Gao, M Wang, F Gao, Y Q Liu, K P Du, S Li, H J Zhang, Y F Yao, Z G Zhou
Objective: To investigate the safety and accuracy of CT-guided intracranial puncture biopsy and the possible influencing factors of postoperative bleeding complications. Methods: A case series study. A retrospective analysis was conducted on 101 patients who underwent CT-guided intracranial puncture biopsy at the First Affiliated Hospital of Zhengzhou University from January 2017 to December 2021. The basic data of patients and the safety and accuracy of CT-guided intracranial puncture biopsy were analyzed statistically...
April 23, 2024: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/38643837/e2f1-regulated-usp5-contributes-to-the-tumorigenic-capacity-of-glioma-stem-cells-through-the-maintenance-of-oct4-stability
#33
JOURNAL ARTICLE
Xiao Jiang, Hongtao You, Yixuan Niu, Yudan Ding, Zhengxin Chen, Huibo Wang, Yuan Xu, Peng Zhou, Li Wei, Danni Deng, Lian Xue, Ya Peng, Yilin Yang, Ligang Fan, Naiyuan Shao
Mesenchymal glioma stem cells (MES GSCs) are a subpopulation of cells in glioblastoma (GBM) that contribute to a worse prognosis owing to their highly aggressive nature and resistance to radiation therapy. Here, OCT4 is characterized as a criticial factor in sustaining the stemness phenotype of MES GSC. We find that OCT4 is expressed intensively in MES GSC and is intimately associated with poor prognosis, moreover, OCT4 depletion leads to diminished invasive capacity and impairment of the stem phenotype in MES GSC...
April 19, 2024: Cancer Letters
https://read.qxmd.com/read/38642129/a-novel-network-based-method-identifies-a-cuproplasia-related-pan-cancer-gene-signature-to-predict-patient-outcome
#34
JOURNAL ARTICLE
Vu Viet Hoang Pham, Toni Rose Jue, Jessica Lilian Bell, Fabio Luciani, Filip Michniewicz, Giuseppe Cirillo, Linda Vahdat, Chelsea Mayoh, Orazio Vittorio
Copper is a vital micronutrient involved in many biological processes and is an essential component of tumour cell growth and migration. Copper influences tumour growth through a process called cuproplasia, defined as abnormal copper-dependent cell-growth and proliferation. Copper-chelation therapy targeting this process has demonstrated efficacy in several clinical trials against cancer. While the molecular pathways associated with cuproplasia are partially known, genetic heterogeneity across different cancer types has limited the understanding of how cuproplasia impacts patient survival...
April 20, 2024: Human Genetics
https://read.qxmd.com/read/38642107/whole-brain-morphologic-features-improve-the-predictive-accuracy-of-idh-status-and-vegf-expression-levels-in-gliomas
#35
JOURNAL ARTICLE
Simin Zhang, Di Chen, Huaiqiang Sun, Graham J Kemp, Yinying Chen, Qiaoyue Tan, Yuan Yang, Qiyong Gong, Qiang Yue
Glioma is a systemic disease that can induce micro and macro alternations of whole brain. Isocitrate dehydrogenase and vascular endothelial growth factor are proven prognostic markers and antiangiogenic therapy targets in glioma. The aim of this study was to determine the ability of whole brain morphologic features and radiomics to predict isocitrate dehydrogenase status and vascular endothelial growth factor expression levels. This study recruited 80 glioma patients with isocitrate dehydrogenase wildtype and high vascular endothelial growth factor expression levels, and 102 patients with isocitrate dehydrogenase mutation and low vascular endothelial growth factor expression levels...
April 1, 2024: Cerebral Cortex
https://read.qxmd.com/read/38641945/multi-omics-technologies-and-molecular-biomarkers-in-brain-tumor-related-epilepsy
#36
REVIEW
Yaoqiang Du, Rusong Li, Danqing Fu, Biqin Zhang, Ailin Cui, Yutian Shao, Zeyu Lai, Rongrong Chen, Bingyu Chen, Zhen Wang, Wei Zhang, Lisheng Chu
BACKGROUND: Brain tumors are one of the leading causes of epilepsy, and brain tumor-related epilepsy (BTRE) is recognized as the major cause of intractable epilepsy, resulting in huge treatment cost and burden to patients, their families, and society. Although optimal treatment regimens are available, the majority of patients with BTRE show poor resolution of symptoms. BTRE has a very complex and multifactorial etiology, which includes several influencing factors such as genetic and molecular biomarkers...
April 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38641744/demographic-bias-in-misdiagnosis-by-computational-pathology-models
#37
JOURNAL ARTICLE
Anurag Vaidya, Richard J Chen, Drew F K Williamson, Andrew H Song, Guillaume Jaume, Yuzhe Yang, Thomas Hartvigsen, Emma C Dyer, Ming Y Lu, Jana Lipkova, Muhammad Shaban, Tiffany Y Chen, Faisal Mahmood
Despite increasing numbers of regulatory approvals, deep learning-based computational pathology systems often overlook the impact of demographic factors on performance, potentially leading to biases. This concern is all the more important as computational pathology has leveraged large public datasets that underrepresent certain demographic groups. Using publicly available data from The Cancer Genome Atlas and the EBRAINS brain tumor atlas, as well as internal patient data, we show that whole-slide image classification models display marked performance disparities across different demographic groups when used to subtype breast and lung carcinomas and to predict IDH1 mutations in gliomas...
April 2024: Nature Medicine
https://read.qxmd.com/read/38640932/identification-of-hypoxic-macrophages-in-glioblastoma-with-therapeutic-potential-for-vasculature-normalization
#38
JOURNAL ARTICLE
Wenying Wang, Tianran Li, Yue Cheng, Fei Li, Shuhong Qi, Min Mao, Jingjing Wu, Qing Liu, Xiaoning Zhang, Xuegang Li, Lu Zhang, Haoyue Qi, Lan Yang, Kaidi Yang, Zhicheng He, Shuaishuai Ding, Zhongyi Qin, Ying Yang, Xi Yang, Chunhua Luo, Ying Guo, Chao Wang, Xindong Liu, Lei Zhou, Yuqi Liu, Weikai Kong, Jingya Miao, Shuanghui Ye, Min Luo, Lele An, Lujing Wang, Linrong Che, Qin Niu, Qinghua Ma, Xia Zhang, Zhihong Zhang, Rong Hu, Hua Feng, Yi-Fang Ping, Xiu-Wu Bian, Yu Shi
Monocyte-derived tumor-associated macrophages (Mo-TAMs) intensively infiltrate diffuse gliomas with remarkable heterogeneity. Using single-cell transcriptomics, we chart a spatially resolved transcriptional landscape of Mo-TAMs across 51 patients with isocitrate dehydrogenase (IDH)-wild-type glioblastomas or IDH-mutant gliomas. We characterize a Mo-TAM subset that is localized to the peri-necrotic niche and skewed by hypoxic niche cues to acquire a hypoxia response signature. Hypoxia-TAM destabilizes endothelial adherens junctions by activating adrenomedullin paracrine signaling, thereby stimulating a hyperpermeable neovasculature that hampers drug delivery in glioblastoma xenografts...
April 16, 2024: Cancer Cell
https://read.qxmd.com/read/38640858/ginsenoside-rg5-inhibits-glioblastoma-by-activating-ferroptosis-via-nr3c1-hspb1-ncoa4
#39
JOURNAL ARTICLE
Guoqing Zhang, Jinpeng Hu, Ao Li, Haiying Zhang, Zhengting Guo, Xinqiao Li, Zinan You, Yongfeng Wang, Zhitao Jing
BACKGROUND: The utilization of Chinese medicine as an adjunctive therapy for cancer has recently gained significant attention. Ferroptosis, a newly regulated cell death process depending on the ferrous ions, has been proved to be participated in glioma stem cells inactivation. PURPOSE: We aim to study whether ginsenoside Rg5 exerted inhibitory effects on crucial aspects of glioma stem cells, including cell viability, tumor initiation, invasion, self-renewal ability, neurosphere formation, and stemness...
April 12, 2024: Phytomedicine
https://read.qxmd.com/read/38640786/aurora-kinase-a-inhibition-plus-tumor-treating-fields-suppress-glioma-cell-proliferation-in-a-cilium-independent-manner
#40
JOURNAL ARTICLE
Jia Tian, Julianne C Mallinger, Ping Shi, Dahao Ling, Loic P Deleyrolle, Min Lin, Habibeh Khoshbouei, Matthew R Sarkisian
Tumor Treating Fields (TTFields) extend the survival of glioblastoma (GBM) patients by interfering with a broad range of tumor cellular processes. Among these, TTFields disrupt primary cilia stability on GBM cells. Here we asked if concomitant treatment of TTFields with other agents that interfere with GBM ciliogenesis further suppress GBM cell proliferation in vitro. Aurora kinase A (AURKA) promotes both cilia disassembly and GBM growth. Inhibitors of AURKA, such as Alisertib, inhibit cilia disassembly and increase ciliary frequency in various cell types...
April 18, 2024: Translational Oncology
keyword
keyword
51908
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.